Lipid Metabolism, Inborn Errors
Metabolic·MeSH: Metabolism, Inborn Errors
1 drug in development·1 company·5 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| mipomersen | TG THERAPEUTICS, INC. (TGTX) |
Frequently asked questions
How many drugs are in development for Lipid Metabolism, Inborn Errors?
BioSniper tracks 1 drug in development for Lipid Metabolism, Inborn Errors across 1 company.
How many clinical trials target Lipid Metabolism, Inborn Errors?
There are 5 clinical trials targeting Lipid Metabolism, Inborn Errors tracked by BioSniper.
Deep-dive into Lipid Metabolism, Inborn Errors
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis